R. Rao Koganty
2007
In 2007, R. Rao Koganty earned a total compensation of $203.6K as Vice President and General Manager Synthetic Biologics Business Unit at Oncothyreon, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $29,305 |
|---|---|
| Option Awards | $25,373 |
| Salary | $141,527 |
| Other | $7,359 |
| Total | $203,564 |
Koganty received $141.5K in salary, accounting for 70% of the total pay in 2007.
Koganty also received $29.3K in non-equity incentive plan, $25.4K in option awards and $7.4K in other compensation.
Rankings
In 2007, R. Rao Koganty's compensation ranked 8,081st out of 8,700 executives tracked by ExecPay. In other words, Koganty earned more than 7.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,081 out of 8,700 | 7th |
Division Services | 1,192 out of 1,256 | 5th |
Major group Engineering, Accounting, Research, Management, And Related Services | 118 out of 121 | 3rd |
Industry group Research, Development, And Testing Services | 47 out of 48 | 2nd |
Industry Commercial Physical and Biological Research | 41 out of 42 | 2nd |
Source: SEC filing on April 29, 2008.
Koganty's colleagues
We found six more compensation records of executives who worked with R. Rao Koganty at Oncothyreon in 2007.
2007
Robert Kirkman
Oncothyreon
Chief Executive Officer
2007
Edward Taylor
Oncothyreon
Chief Financial Officer
2007
D Kirkpatrick
Oncothyreon
Chief Scientific Officer
2007
Marilyn Olson
Oncothyreon
Vice President, Clinical Regulatory Affairs
2007
Robert Aubrey
Oncothyreon
Former Vice President, Business Development
2007
Gary Christianson
Oncothyreon